To identify patients at risk from renal bone disease we compared the demographic characteristics of 243 patients with end stage renal failure grouped according to the presence (97 (40%)) or absence of severe renal bone disease as judged by histological criteria. Youth, female sex, tubulointerstitial types of nephropathy, and a long duration of uraemia were all identified as significant independent risk factors for the development of bone disease. The relative risks from being female and having tubulointerstitial renal disease were separately identifiable when the estimated observation of renal failure was short (less than four years).
Introduction
The prevalence of renal osteodystrophy in patients with end stage chronic renal failure depends on the criteria used for diagnosis. Nevertheless, it is apparent that a minority have severe bone disease whether this is judged by bone histology,} 2 radiographic findings,3 4 or symptoms.4 Surprisingly little is known about the factors that determine which patients will develop severe bone disease, although such knowledge might be of value in understanding the pathogenesis of the disorder, predicting which patients are at risk, and planning prophylaxis. Factors considered have included the age and sex of patients3 [5] [6] [7] and the duration and nature of their renal disease,3 4 89 but the interrelations between these putative risk factors are not clear. To define the characteristics of the population susceptible to bone disease we examined the interrelations between renal bone disease and various demographic features of a large, unselected series of patients with end stage uraemia.
Patients and methods

PATIENTS
Two hundred and thirty six patients (aged years) with end stage chronic renal failure were studied within six months after beginning regular haemodialysis treatment. All patients entering the haemodialysis-transplantation programme at the Oxford Renal Unit between 1970 and 1979 were included in the study, and the population was not otherwise selected. These patients had received no previous treatment for bone disease apart from aluminium hydroxide for control of hyperphosphataemia, but none was hypophosphataemic. In particular, vitamin D analogues or metabolites and anticonvulsant drugs were not given.
We also studied seven patients (aged 14-49) with chronic progressive renal failure who had developed symptomatic bone disease requiring treatment before end stage was reached. These patients were assessed at the time of their bone biopsy and before the start of specific treatment. Plasma creatinine concentrations at the time of assessment ranged from 480 to 640 pmol/l (5-3-7-1 mg/100 ml), and all seven eventually required dialysis treatment. In including these patients we assumed that their bone disease would not have improved spontaneously by the time dialysis was required.
METHODS
Transiliac bone biopsy specimens were obtained from all 243 patients. Undecalcified sections of trabecular bone were stained and examined according to methods previously described.9 0 Osteomalacia was diagnosed if five or more osteoid lamellae were visible under polarised light in any osteoid seam."' Osteitis fibrosa was diagnosed if marrow fibrosis extending beyond resorption cavities was present. 10 Patients, without osteomalacia or osteitis fibrosa according to these criteria were classified as having no bone disease or mild disease, as the appearance of bone in these patients was not invariably normal. Radiographic skeletal surveys were performed in 239 patients (incomplete in four patients). The radiographs were examiined by two of us for the presence of subperiosteal erosions of the phalanges, clavicles, or elsewhere and for osteosclerosis of the spine or elsewhere. Activity of alkaline phosphatase was measured in plasma by Vickers multiple channel analyser (p-nitrophenylphosphate substrate) in 239 patients. The age and sex of all patients were noted, and, as far as possible, the cause and duration of renal failure were also established. The duration of renal failure was defined as the interval (to the nearest year) between the first recorded finding of a raised serum concentration of urea or creatinine and the initiation of regular haemodialysis treatment. This information was available in 235 patients. The causes of renal failure were established by clinical, biochemical, radiographic, or histological means in 239 patients and divided according to whether the renal lesion affected principally the glomeruli or renal vasculature or whether tubulointerstitial disease was a predominant feature ( Because renal bone disease is profoundly modified by haemodialysis and transplantation, and because we wished to determine the factors influencing the prevalence of bone disease at end stage renal failure before these procedures, survival analysis was not considered to be appropriate. We therefore examined the association between the demographic features of the population and the presence of histological and radiographic findings by the x2 test. The effect of multiple categorised factors on the probability of developing bone disease was assessed using the technique of relative risk analysis.12 13 Student's t test for unpaired observations was used to compare mean activities of aLkaline phosphatase and the estimated duration of renal failure in various subgroups. Alkaline The results (figure and table VI) showed that, for patients with a short history of renal failure, both--interstitial nephropathy and being female had an adverse effect on the risk of developing bone disease and that these effects could not be accounted for by intercorrelations between the factors. In patients with a long history of renal failure, however, neither being female nor the presence of interstitial renal disease was a significant risk factor. A long duration of renal failure was a particularly significant risk factor in men with glomerular or vascular forms of renal disease (relative risk (table  VI) ).
Discussion
Each of the demographic features studied-age, sex, type of renal disease, and estimated duration of renal failure-appeared independently to influence the prevalence of bone disease in patients reaching end stage uraemia using our criteria for the presence and absence of bone disease. The classification of the presence or absence of bone disease by the radiographic or confirmed that the prevalence of bone disease is higher in children and adolescents than in adults, whether assessed radiographically, biochemically, or histologically.8 57 In contrast, there was no relation between age and bone disease among the adult population. The susceptibility of the young may be related to the higher rate of bone remodelling"' and greater requirements for vitamin D and calcium. 19 The normal adolescent growth spurt is accompanied by increased serum concentrations of 1,25-dihydroxyvitamin D (1,25(OH,)D) ,20 but in uraemia production of this hormone is impaired"' and both the retardation of growth and the severity of hyperparathyroid bone disease may be aggravated by impaired production of 1,25-dihydroxyvitamin D." 2' It would perhaps not be surprising therefore if the effects of 1,25-dihydroxyvitamin D deficiency were more pronounced in adolescents.
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Relative risk of +3 BRITISH MEDICAL JOURNAL VOLUME 290 26 JANUARY 1985 of renal failure seen in these patients. Our analysis suggests, however, that the nature of the renal disease and the duration of renal failure are independent risk factors. The effect of sex on the prevalence of bone disease was not spurious despite the unequal distribution of sex between the two categories of renal disease. This unexpected finding has recently been independently reported in patients receiving haemodialysis7 but is contrary to an earlier study using fewer patients and radiographic criteria alone.'
Precedents for such a sex difference in metabolic bone disease include the more appreciable age related bone loss in women than men26 and the greater incidence of primary hyperparathyroidism." These differences are probably due to diminished production of gonadal steroids, a phenomenon also observed in chronic uraemia.28 29 Gonadal steroids may play a more critical part than hitherto recognised in the skeletal metabolism of women with chronic renal failure.
Other factors, not considered in this study, are undoubtedly important. Examples include privational deficiency of vitamin D, 30 
